TUSAMITAMAB RAVTANSINE
UNII DSS3BE2ZXN

Substance Identification & Data

This profile provides standardized clinical and technical data for Tusamitamab Ravtansine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DSS3BE2ZXN.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2254086-60-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

DSS3BE2ZXN

CAS Registry Number

2254086-60-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TUSAMITAMAB RAVTANSINE

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C117229

National Cancer Institute reference terminology for clinical and research data.

INN ID

11356

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JK-225

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tusamitamab Ravtansine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TUSAMITAMAB RAVTANSINE

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5) (HUMAN MONOCLONAL SAR408377 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL SAR408377 .KAPPA.-CHAIN, DIMER, AMIDE WITH N2'-(4-((3-CARBOXYPROPYL)DITHIO)-4-METHYL-1-OXOPENTYL)-N2'-DEACETYLMAYTANSINE

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5 (CARCINOEMBRYONIC ANTIGEN, MECONIUM ANTIGEN 100, ANTIGEN_CD66E)) HUMANIZED MOUSE MONOCLONAL ANTIBODY; .GAMMA.1 HEAVY CHAIN (1-449) (VH(MUS MUSCULUS IGHV5-12-1*01 (87%)-(IGHD)-IGHJ3*01 (93%)/HOMO SAPIENS IGHV3-23*01 (77%) IGHJ4*01 (93%)) (8.8.13) (1-120)-HOMO SAPIENS IGHG1*01 (CH3(K107>DEL(450))) (121-449) (223-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-214') (V-KAPPA (MUS MUSCULUS IGKV12-44*01 (87%)-IGKJ4*01/HOMO SAPIENS IGKV1-39*01 (82%)-IGKJ2*02 (91%))(6.3.9) (1'-107') HOMO SAPIENS IGKC*01 (108'-214')), DIMER (229-229'':232-232'')-BISDISULFIDE, PRODUCED IN CHO CELL, GLYCOFORM ALFA; 3 OR 4 (N) LYSINES ARE N6 SUBSTITUTED BY RAVTANSINE

MAYTANSIN-LOADED ANTI-CEACAM5 MAB

TUSAMITAMAB RAVTANSINE [INN]

TUSAMITAMAB RAVTANSINE [USAN]

TUSAMITAMAB RAVTANSINE [WHO-DD]